Why Publish with us
- Founded in 1964 by the Korean Society for Biochemistry and Molecular Biology, we are Korea's first biochemistry journal.
- We are devoted to the latest developments and discoveries in translational and biomedical research fields.
- We cover genetic, molecular, and cellular studies of human physiology and diseases, and we welcome papers dealing with clear in vivo relevance and novelty, and basic discoveries with clinical relevance.
- Open access publication ensures that your article can be easily discovered, accessed, used, and shared, maximising your impact and acting as a springboard for further discovery.
Aims and scope of journal
Experimental & Molecular Medicine (EMM) is Korea's first biochemistry journal (founded in 1964) and is relaunched in 1996 as an Open Access, fully peer-reviewed international journal. It is a medical research journal devoted to publishing the latest developments in translational research and the recent discoveries in the biomedical field. Submission is encouraged of papers that involve genetic, molecular and cellular studies of human physiology and diseases. The journal seeks to highlight the improved clinical benefits for human health from experimental and translational research performed using specific molecular tools. Studies that encompass basic discoveries with clinical relevance as well as articles dealing with clear in vivo relevance and novelty will also be welcomed. Experimental & Molecular Medicine is an open access, online-only journal.
Topics of particular interest within the journal's scope include, but are not limited to, those listed below:
- Cancer biology
- Cardiovascular biology
- Genetics and genomics
- Gene therapy
- Metabolic diseases
- Stem cells and regenerative medicine
- Physiology and diseases
- Molecular Medicine
The journal publishes peer-reviewed Original Articles and Reviews. In addition, Research Summaries are provided for selected articles. Editorial articles are brief comments written by the editor(s) of the journal or by guest editor(s) of Special Features based on the contents of the current issue or topical subjects that fall within the scope of the journal.
Reviews can be submitted by authors without invitation but authors are encouraged to submit an abstract of the review to the Editor-in-Chief (firstname.lastname@example.org) to consider for suitability prior to submission of a full article. Submissions of Review articles from outstanding graduate students are also encouraged under the following conditions:
- An abstract of the review should be submitted to the Editor-in-Chief (email@example.com) to consider for suitability prior to the submission of a full article
- The student's supervisor who has the most expertise in the area being reviewed must be a participatory co-author on the paper
- The article should encompass a critical assessment of an area: the timeliness of this assessment should be explicitly justified
Citing articles in Experimental & Molecular Medicine
EMM uses the digital object identifier (DOI) as the primary means to identify papers, instead of the more traditional Volume / Issue / Consecutive page numbers. The DOI is an international, public, “persistent identifier of intellectual property entities” in the form of a combination of numbers and letters. For Nature Research content the DOI is assigned to an item of editorial content, providing a unique and persistent identifier for that item. The DOI system is administered by the International DOI Foundation, a not-for-profit organization. CrossRef, a not-for-profit organization, makes the DOI a reference linking standard and enables cross-publisher linking. It also maintains the lookup system for DOIs. Nature Research is a founding, and board, member of CrossRef.
To cite articles in EMM, you can give the paper's DOI at the end of the citation. For example, Experimental & Molecular Medicine papers should be cited in the form as specified by a journal or for example: Author(s) (Year) Article Title Exp Mol Med, page(s); (DOI 10.1038/emm.YEAR.XXX).
For your background information, the DOI has two components, a prefix (before the slash) and a suffix (after the slash). The prefix is a DOI resolver server identifier (10) and a unique identifier assigned to the publisher; for example, the identifier for Nature Research is 1038 and the entire DOI prefix for an article published by Nature Research is 10.1038. The suffix is an arbitrary number provided by the publisher; it can be composed of numbers and/or letters and does not necessarily have any systematic significance. Each DOI is registered in a central resolution database that associates it with one or more corresponding web locations (URLs).
Article and journal metrics
Article metrics such as number of downloads, citations and online attention are available from each article page, and provide an overview of the attention received by a paper.
The 2021 journal citation metrics for Experimental & Molecular Medicine are as follows:
2-year Impact Factor* (2021): 12.172
5-year Impact Factor* (2021): 11.587
Immediacy index*: 1.772
Eigenfactor® score*: 0.01698
Article influence score*: 2.432
JCR Rank*: MEDICINE, RESEARCH & EXPERIMENTAL 12/139; BIOCHEMISTRY & MOLECULAR BIOLOGY 21/297
Journal Citation Indicator*: 1.50
The latest speed and usage metrics for Experimental and Molecular Medicine are as follows:
- 25 days to first decision for all manuscripts (Median)
- 1,987,141 Downloads (in 2021)
- 1,303 Altmetric mentions (2021)
*2022 Journal Citation Reports® Science Edition (Clarivate Analytics, 2022)
- Google Scholar
- Science Citation Index & Biological Abstracts (ISI - Clarivate Analytics)
- MedLine (Pubmed)
- Chemical Abstracts (CAS)
- EM Base (Elsevier Scopus)
ISSN and eISSN
The international standard serial number (ISSN) for Experimental & Molecular Medicine is 1226-3613 and the electronic international standard serial number (eISSN) is 2092-6413.
The articles are being published online on a daily basis as soon as when ready to published, and archived monthly.
This journal was supported by the Korean Federation of Science and Technology Societies Grant funded by the Korean Government(Ministry of Education).